Madrigal Pharmaceuticals Inc — Statistiche Finanziarie Trimestrali (NASDAQ:MDGL) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -104.49 M-88.89 M-47.05 M79.85 M-133.46 M -189.55 M Flussi di cassa derivanti dalle attività di investimento -47.95 M163.88 M47.86 M-207 M27.58 M 32.32 M Liquidità derivante dalle attività di finanziamento 19.77 M8.64 M1.74 M236.65 M8.96 M 255.98 M Liquidità libera -104.68 M-88.89 M-47.05 M75.99 M-133.07 M -193.02 M

Notizie

Wolfe Research conferma rating Peerperform su azioni Madrigal

United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?

Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?

Why Is Corcept (CORT) Up 11.7% Since Last Earnings Report?

ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms

ALT Pemvidutide Explained: What Makes It Different in MASH

Tracking John Paulson’s Paulson & Company Portfolio – Q4 2025 Update

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

EVP di Madrigal Pharmaceuticals Dier vende azioni per 854.000$

Madrigal Pharmaceuticals EVP Dier sells $854k in stock

Il CEO di Madrigal Pharmaceuticals Sibold vende azioni per 718k$

Madrigal Pharmaceuticals CEO Sibold sells $718k in shares